Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones

Bone

Volumn 20, Issue 4, 1997, Pages 347-353

  Weinreb, Miron ^a   Rutledge, S J ^b   Rodan, G A ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bone; Bone formation; Early response genes; egr 1; fos; jun; Prostaglandin E2; Rat

Indexed keywords

ANABOLIC AGENT; MESSENGER RNA; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; EARLY RESPONSE GENE; GENE INDUCTION; IN SITU HYBRIDIZATION; METAPHYSIS; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C JUN; OSSIFICATION; OSTEOBLAST; RAT; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; TARGET CELL; TIBIA;

ANIMALS; BLOTTING, NORTHERN; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; DINOPROSTONE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION; INJECTIONS, SUBCUTANEOUS; OSTEOBLASTS; OXYTOCICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIBIA; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 0030987186     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00011-2     Document Type: Article

References (74)

1. Abramovitz, M., Adam, M., Boie, Y., Grygorczyk, R., Rushmore, T. H., Nguyen, T., Funk, C. D., Bastien, L., Bawyer, N., Rochette, C., Slipetz, D. M., and Metters, K. M. Human prostanoid receptors: Cloning and characterization. Adv Prostaglandins Thromboxane Leukot Res 23:499-504; 1995.
2. 3 prostanoid receptor. FEBS Lett 338:170-174; 1994.
3. Angel, P. and Karin, M. The role of jun, fos and the AP-I complex in cell-proliferation and transformation. Biochem Biophys Acta 1072:129-157; 1991.
4. 2 subtype. J Biol Chem 269:11873-11877; 1994.
5. Bergmann, P. and Schoutens, A. Prostaglandins and bone. Bone 16:485-488; 1995.
6. 1α on biosynthesis of collagen. Nature New Biol 239:246; 1972.
7. Cao, X., Guy, G. R., Sukhatme, V. P., and Tan, Y. H. Regulation of the egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. J Biol Chem 267:1345-1349; 1992.
8. Centrella, M., Casinghino, S., and McCarthy, T. L. Differential actions of prostaglandins in separate populations from fetal rat bone. Endocrinology 135: 1611-1620; 1994.
9. 1. J Pathol 139:383-397; 1983.
10. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159; 1987.
11. Coleman, R. A., Eglen, R. M., Jones, R. L., Narumiya, S., Shimizu, T., Smith, W. L., Dahlen, S. E., Drazen, J. M., Gardiner, P. J., Jackson, W. T., Jones, T. R., Krell, R. D., and Nicosia, S. Prostanoid and leukotriene receptors: A progress report from the IUPHAR working parties on classification and nomenclature. Adv Prostaglandins Thromboxane Leukot Res 23:283-285; 1995.
12. 2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells. J Bone Miner Res 7:555-561; 1992.
13. 2 and activation of protein kinase C. J Biol Chem 269:27258-27263; 1994.
14. De Tongi, P., Niman, H., Raymond, V., Sawchenko, P., and Verma, I. M. Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol 8:2251-2256; 1988.
15. Dobing, H. and Turner, R. T. Evidence that intermittent treatment with PTH increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638; 1995.
16. Dony, C. and Gruss, P. Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue. Nature 328:711-714; 1987.
17. Drvaric, D. M., Park, W. J., Wyly, J. B., Dooley, K. J., Plauth, W. H., and Schmitt, E. W. Prostaglandin-induced hyperostosis: A case study. Clin Orthop 246:300-304; 1989.
18. Fagot, D., Buquuet-Fagot, C., and Mester, J. Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: comparison with phorbol esters and insulin. Endocrinology 132:1729-1734; 1993.
19. Fuller, K. and Chambers, T. J. Effect of arachidonid acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res 4:209-215; 1989.
20. Gamelli, R. L., He, L. K., and Liu, H. Marrow granulocyte-macrophage progenitor cell response to bum injury as modified by endotoxin and indomethacin. J Trauma 37:339-346; 1994.
21. Grigoriadis, A. E., Schellander, K., Wang, Z. Q., and Wagner, E. F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122: 685-701; 1993.
22. 2 stimulates preosteoblast replication: An autoradiographic study in cultured fetal rat calvariae Exp Cell Res 212:314-320; 1994.
23. 2 stimulates DNA synthesis by a cyclic AMP-dependent pathway in osteoblastic clone MC3T3-E1. J Cell Physiol 18:155-161; 1986.
24. Herrlich, P. and Ponta, H. Nuclear oncogenes convert extracellular stimuli into changes in the genetic program. Trends Genet 5:112-116; 1989.
25. Hill, C. S. and Treisman, R. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J 14:5037-5047; 1995.
26. 2 in the rat. Bone Miner 21:219-236; 1993.
27. 2 in growing rats: Increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif Tissue Int 37:148-157; 1985.
28. 2 on tibial diaphyseal bone in male rats. Bone Miner 15:33-55; 1991.
29. 2. Bone 8:171-178; 1987.
30. 2 administration. Acta Orthop Scand 59: 464-466; 1988.
31. Kinane, T. B., Finder, J. D., Kawashima, A., Brown, D., Abbate, M., Shang, C., Fredericks, W. J., Rauscher, F. J., Sukhatme, V. P., and Ercolani, L. Growth of LLC-PK1 renal cells is mediated by egr-1 upregulation of G protein αi-2 protooncogene transcription. J Biol Chem 269:27503-27509; 1994.
32. 2α in human ciliary smooth muscle cells. Invest Ophtalmol Vis Sci 35: 242-250; 1994.
33. Liu, J., Clegg, C. H., and Shoyab, M. Regulation of egr-1, c-jun and c-myc gene expression by oncostatin M. Cell Growth Different 3:307-313; 1992.
34. Lauritzen, D. B., Balena, R., Shea, M., Seedor, J. G., Markatos, A., Le, H. M., Toolan, B. C., Myers, E. R., Rodan, G. A., and Hayes, W. C. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res 8:871-879; 1993.
35. Machwate, M., Jullienne, A., Moukhtar, M., and Marie, P. J. Temporal variation of c-fos proto-oneogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J Cell Biochem 57:62-70; 1995.
36. 1 stimulates mandibular bone formation in vivo. J Oral Pathol 17:500-505; 1988.
37. Mass, A., Grohe, C., Oberdorf, S., Sukhatme, V. P., Vetter, H., and Neyses, L. Mitogenic signal control translation of the early growth response gene-1 in myogenic cells. Biochem Biophys Res Commun 202:1337-1346; 1994.
38. McCabe, L. R., Kockx, M., Lian, J., Stein, J., and Stein, G. Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res 218:255-262; 1995.
39. Meerpohl, H. G. and Bauknecht, T. Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions. Prostaglandins 31:961-972; 1986.
40. 1: Quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets. Bone 14:143-151; 1993.
41. 2. Biochem Mol Biol Int 29:1023-1028; 1993.
42. 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 11:103-113; 1990.
43. 2. Calcif Tissue Int 50:80-87; 1992.
44. 2. Bone 14:655-659; 1993.
45. Narumiya, S. Structures, properties and distributions of prostanoid receptors. Adv Prostaglandin Thromboxane Leukot Res 23:17-22; 1995.
46. Nocka, K. H., Ottman, O. G., and Pelus, L. M. The role of marrow accessory cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E. Leukot Res 13:527-534; 1989.
47. Onyia, J. E., Bidwell, J., Herring, J., Hulman, J., and Hock, J. M. In vivo, human PTH 1-34 transiently stimulates immediate early response gene expression but not proliferation in trabecular bone cells of young rats. Bone 17:479-484; 1995.
48. 2α-induced mitogenesis in MC3T3-E1 osteoblasts: Role of protein kinase-C mediated tyrosine phosphorylation. Endocrinology 132:1505-1513; 1993.
49. 2 on bone formation in cultured fetal rat calvariae: Role of insulin-like growth factor-β. Endocrinology 133:1504-1510; 1993.
50. Raisz, L. G., Pilbeam, C. C., and Fall P. M. Prostaglandins: Mechanisms of action and regulation of production in bone. Osteoporosis Int (Suppl 1): S136-S140; 1993.
51. 1 infusion in an infant with congenital heart disease. Radiology 142:657-658; 1982.
52. Rupprecht, H. D., Dann, P., Sukhatme, V. P., Sterzel, R. B., and Coleman, D. L. Effect of vasoactive agents on induction of egr-1 in rat mesanglial cells: Correlation with mitogenicity. Am J Physiol 263:F623-F636; 1992.
53. Sandberg, M., Vuorio, T., Hirvonen, H., Alitalo, K., and Vuorio, E. Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones. Development 102:461-470; 1988.
54. 2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitro. J Bone Miner Res 7:1157-1163; 1992.
55. Schon, A., Michiels, L., Janowski, M., Merregaert, J., and Erfle, V. Expression of proto-oncogenes in murine osteosarcomas. Int J Cancer 38:67-74; 1986.
56. 2: Induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10:474-487; 1995.
57. Shinar, D. M., Endo, N., Halperin, D., Rodan. G. A., and Weinreb, M. Differential expression of IGF-1 and IGF-2 mRNA in growing rat bone. Endocrinology 132:1158-1167; 1993.
58. 2 induces c-fos expression by a cAMP-independent mechanism in glomerular mesanglial cells. Exp Cell Res 215:137-144;1994.
59. Subramanian, M., Oursler, M. J., Rasmussen, K., Riggs, B. L., and Spelsberg, T. C. TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells. J Cell Biochem 57:52-61; 1995.
60. 2 on bone mass of long bones and calvariae of young rats. Biochem Biophys Res Commun Submitted.
61. Suva, L. J., Ernst, M., and Rodan, G. A. Retinoic acid increases Zif268 early gene expression in rat preosteoblastic cells. Mol Cell Biol 11:2503-2510; 1991.
62. Suva, L. J., Harm, S. C., Gardner, R. M., and Thiede, M. A. In vivo regulation of Zif268 messenger RNA expression by 17β-estradiol in the rat uterus. Mol Endocrinol 5:829-835; 1991.
63. Taniguchi, S., Shibuya, T., Harada, M., and Niho, Y. Prostaglandin-mediated suppression of in vitro growth of erythroid progenitor cells. Kidney Int 36: 712-718; 1989.
64. 2 in rapidly growing rats: Depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. Bone 6:79-86: 1985.
65. 1 in infants with cyanotic congenital heart disease. J Pediatrics 97: 834-836; 1980.
66. Vairo, G., Argyriou, S., Bordun, A. M., Whitty, G., and Hamilton, J. A. Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to colony stimulating factor-1. J Biol Chem 265:2692-2701; 1990.
67. Verma, I. M. and Sassone-Corsi, P. Proto-oncogene fos: Complex but versatile regulation. Cell 51:513-514; 1987.
68. 1 subtype of prostaglandin E receptor. J Biol Chem 268:20175-20178; 1993.
69. Weinreb, M., Shinar, D., and Rodan, G. A. Different pattern of alkaline phosphatase, osteopontin and osteocalcin expression in developing rat bone visualized by in-situ hybridization. J Bone Miner Res 5:831-842; 1990.
70. 2 in rats. J Bone Miner Res 11(Suppl 1):S139; 1996 (abstr).
71. 2 in young rats increases the osteogenic capacity of bone marrow. Bone (accepted).
72. 2 induces early-response genes in rat bones. J Bone Miner Res 10(Suppl 1):S250; 1995 (abstr).
73. Wu, J. X., Carpenter, J. M., Gresens. C., Keh, R., Niman, H., Morris, J. W. S., and Mercola, D. The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 5:989-1000; 1990.
74. 2 in rats. Calcif Tissue Int 52:57-61; 1993.